Citations

Showing 10 of 108104 citations.

Pacemakers as Atrial Fibrillation Detectors: Finding Racial Differences and Opportunities for Preventing Stroke
Meschia, James F.

Mayo Clinic

Journal of the American Heart Association | September 14, 2018 | Volume: 5 | Issue: 2 | Pages: No page available

10.1161/jaha.115.003090 | PMID 26873690 Get It

Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction
Wessler, Jeffrey D. , Kaye, David M. , Gustafsson, Finn , Petrie, Mark C. , Hasenfuβ, Gerd, Borlaug, Barry A. , Komtebedde, Jan , Feldman, Ted , Shah, Sanjiv J. , Advisors, on behalf of the REDUCE-LAP-HF Trial Investigators and, Borlaug, Barry A , Kaye, David M , Petrie, Mark C , Shah, Sanjiv J , Lam, Carolyn S.P. , Burkhoff, Daniel , Advisors, on behalf of the REDUCE-LAP-HF Trial Investigators and, Gustafsson, Finn

Mayo Clinic

Circulation: Heart Failure | September 14, 2018 | Volume: 11 | Issue: 8 | Pages: No page available

10.1161/circheartfailure.117.004540 | PMID 30354556 Get It

Background Interatrial shunt device (IASD) effects have been described in patients with heart failure and ejection fractions (EFs) ≥40%. However, baseline characteristics that correlate with greatest hemodynamic effects are unknown. On the basis of fundamental principles, we hypothesized that larger pressure gradients between left and right atria would yield greater shunt flow and greater hemodynamic effects. Methods and Results REDUCE LAP-HF (Reduce Elevated Left Atrial Pressure in Patients With Heart Failure) was a multicenter study that investigated IASD safety and performance. Sixty-four patients with EF ≥40% underwent device implantation followed by hemodynamic assessments at rest and exercise, including pulmonary capillary wedge pressure (PCWP, surrogate for left atrial pressure) and central venous pressure (CVP). At 6 months, IASD resulted in an average pulmonary-to-systemic blood flow ratio of 1.27 and increased exercise tolerance. The PCWP-CVP gradient (ie, the driving pressure for shunt flow) decreased at peak exercise from 16.8±6.9 to 11.4±5.5 mm Hg, because of increased CVP (17.5±5.4 to 20.3±7.9 mm Hg; P =0.04) and decreased PCWP (34.1±7.6 to 31.6±8.0 mm Hg; P =0.025). Baseline PCWP-CVP gradient during exercise correlated with changes of both PCWP-CVP and PCWP: Δ(PCWP-CVP)=10.0−0.89·(PCWP-CVP) baseline ( r 2 =0.56) and ΔPCWP=7.54−0.60·(PCWP-CVP) baseline ( P =0.001). Hemodynamics of patients with EF ≥50% and those with EF <50% responded similarly to IASD. Conclusions In heart failure patients with EF ≥40%, IASD significantly reduced PCWP and PCWP-CVP at peak exercise. Patients with higher baseline PCWP-CVP gradient had greater reductions in both parameters at follow-up. Results were sustained through 12 months and were independent of whether EF was ≥50% or between 40% and 49%. Additional studies will help further define the baseline hemodynamic predictors of exercise, hemodynamic, and clinical efficacy of the IASD. Clinical Trial Registration URL: https://www.clinicaltrials.gov . Unique identifier: NCT01913613.
The American Brachytherapy Society and the American Radium Society Appropriate Use Criteria Genitourinary Committee Endorse the American Society of Clinical Oncology/Cancer Care Ontario Guidelines
Chang, Albert J. , McBride, Sean M. , Keyes, Mira , Chung, Hans T. , Cox, Brett, Demanes, D. Jeffrey, Hsu, I.-Chow, Krauss, Daniel , Orio, Peter F. , Roach, Mack , Venkat, Puja , Vigneault, Éric , McBride, Sean, Davis, Brian J. , Cox, Brett W, Crook, Juanita , Demanes, David J, Kamrava, Mitchell, Krauss, Daniel J, Morton, Gerard , Orio Iii, Peter F, Roach Iii, Mack, Venkat, Puja S, Zeléfsky, Michael J. , Kamrava, Mitchell R.

Mayo Clinic

Journal of Clinical Oncology | September 13, 2018 | Volume: 36 | Issue: 33 | Pages: 3342-3344

10.1200/jco.18.00626 | PMID 30212298 Get It

Basic Fuchsin as a Nuclear Stain for Fungi
DeLamater, Edward D.

Mayo Clinic

Mycologia | September 13, 2018 | Volume: 40 | Issue: 4 | Pages: 423-429

10.1080/00275514.1944.12017720 Get It

An Academic Medical Center’s Learners’ Perceptions of Health Disparities
Greene, Eddie L., Quirindongo-Cedeño, Onelis, Weavers, Karen M. , Bock, Martha J. , Soto, Miguel Valdez , Cornelius, Katherine , Balls-Berry, Joyce E, Greene, Eddie, Weavers, Karen, Brockman, Tabetha A. , Bock, Martha, Patten, Christi A. , Enders, Felicity T, Balls‐Berry, Joyce E. , McCormick, Jennifer Blair , Enders, Felicity

Mayo Clinic

PRiMER | September 13, 2018 | Volume: 2 | Issue: No issue available | Pages: No page available

10.22454/primer.2018.867250 | PMID 32818191 Get It

Introduction: Lack of health equity ultimately leads to unequal treatment of diverse patients and contributes to the growing disparities seen in national health. Academic medical centers should consider providing health care providers and biomedical researchers training on how to identify and address health disparities. Methods: The authors led an introductory health disparities course for graduate students and research and clinical fellows at an academic medical center in the Midwest. We compared pre/postcourse assessments to determine changes in learners’ perceptions and knowledge of health disparities using an unpaired analysis to permit inclusion of responses provided only at baseline. Results: Sixty-two learners completed preassessment, with 56 completing the postassessment (90%). In the postcourse assessment, learners reported an increase in knowledge of disparities and had changes in their perceptions of health disparities linked to treatment of different patient groups based on demographic characteristics. There was a statistically significant difference in learners’ perceptions of how patients are treated based on gender identity (P=0.02) and sexual orientation (P=0.04). Conclusions: The results detail how an academic medical center can provide training on health disparities for diverse learners. This study underscores the influence of health disparities from the perspective of learners who conduct biomedical research and patient care. This course serves a model for introductory-level health disparities courses.
Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus
Steinhart, A. Hillary , Bressler, Brian , Khanna, Reena , Afif, Waqqas , Bernstein, Çharles N. , Bitton, Alain , Borgaonkar, Mark , Chauhan, Usha, Halloran, Brendan P. , Jones, Jennifer , Kennedy, Erin , Meddings, Jonathan B., Plamondon, Sophie , Rosenfeld, Greg , Seow, Cynthia H. , Williams, Chadwick, Panaccione, Remo , Targownik, Laura E. , Marshall, John K. , Bernstein, Charles Noah , Leontiadis, Grigorios I. , Loftus, Edward V. , Moayyedi, Paul , Murthy, Sanjay K. , Schwartz, David A.

Mayo Clinic

Journal of the Canadian Association of Gastroenterology | September 13, 2018 | Volume: 1 | Issue: 4 | Pages: 141-154

10.1093/jcag/gwy047 | PMID 31799497 Get It

Persistent ST-Segment Elevation
Viscuse, Paul V. , Foley, Thomas A. , Michelena, Héctor I.

Mayo Clinic

Circulation | September 13, 2018 | Volume: 138 | Issue: 11 | Pages: 1166-1168

10.1161/circulationaha.118.036584 | PMID 30354381 Get It

Understanding of Users' Response to the Intervention of FDA's New Deeming Rules in Twitter
Luo, Yin , Sun, Song , Leischow, Scott J. , Li, Qiudan , Sun, Song, Zeng, Daniel Dajun

Mayo Clinic

Proceedings of the 2nd International Conference on Medical and Health Informatics | September 13, 2018 | Volume: No volume available | Issue: No issue available | Pages: 1-8

10.1145/3239438.3239439 Get It

Survivin IPF: Targeting Cellular Metabolism to Promote Apoptosis in IPF Fibroblasts
Jones, Dakota L. , Ligresti, Giovanni

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | September 13, 2018 | Volume: 60 | Issue: 1 | Pages: 5-6

10.1165/rcmb.2018-0270ed | PMID 30211627 Get It

Telemedicine in long-term care of glaucoma patients
Odden, Jamie L., Khanna, Cheryl L. , Choo, Clara M, Zhao, Bingying, Shah, Saumya M. , Stalboerger, Gina Marie, Bennett, Jeffrey, Schornack, Muriel , Stalboerger, Gina M, Bennett, Jeffrey R., Schornack, Muriel M, Choo, Clara M, Zhao, Bingying, Schornack, Muriel

Mayo Clinic

Journal of Telemedicine and Telecare | September 13, 2018 | Volume: 26 | Issue: 1-2 | Pages: 92-99

10.1177/1357633x18797175 | PMID 30208751 Get It

Introduction This manuscript describes data from an original study, simulating a tele-glaucoma programme in an established clinic practice with an interdisciplinary team. This is a ‘real life’ trial of a telemedicine approach to see a follow-up patient. The goal is to evaluate the accuracy of such a programme to detect worsening and/or unstable disease. Such a programme is attractive since in-clinic time could be reduced for both the patient and provider. This study evaluates agreement between in-person and remote assessment of glaucoma progression. Methods A total of 200 adult glaucoma patients were enrolled at a single institution. The in-person assessment by an optometrist or glaucoma specialist at time of enrolment was used as the gold standard for defining progression. Collated clinical data were then reviewed by four masked providers who classified glaucoma as progression or non-progression in each eye by comparing data from enrolment visit to data from the visit immediately prior to enrolment. Agreement of glaucoma progression between the masked observer and the in-person assessment was determined using Kappa statistics. Intra-observer agreement was calculated using Kappa to compare in-person to remote assessment when both assessments were performed by the same provider ( n = 279 eyes). Results A total of 399 eyes in 200 subjects were analysed. Agreement between in-person versus remote assessment for the determination of glaucoma progression was 63%, 62%, 69% and 68% for each reader 1–4 (kappa values = 0.19, 0.20, 0.35 and 0.33, respectively). For intra-observer agreement, reader 1 agreed with their own in-person assessment for 65% of visits (kappa = 0.18). Discussion Intra-observer agreement was similar to the agreement for each provider who did not see the patient in person. This similarity suggests that telemedicine may be equally effective at identifying glaucomatous disease progression, regardless of whether the same provider performed both in-clinic and remote assessments. However, fair agreement levels highlight a limitation of using only telemedicine data to determine progression compared with clinical detail available during in-patient assessment.